Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation-Reference-Cited by-同舟云学术

Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation

Published:2015-07 Issue:7 Volume:41 Page:920-926
ISSN:0748-7983
Container-title:European Journal of Surgical Oncology (EJSO)
language:en
Short-container-title:European Journal of Surgical Oncology (EJSO)

Author:

Klevebro F.^ORCID,Johnsen G.,Johnson E.,Viste A.,Myrnäs T.,Szabo E.,Jacobsen A.-B.^ORCID,Friesland S.,Tsai J.A.,Persson S.,Lindblad M.,Lundell L.,Nilsson M.

Funder

Swedish Society of Medicine

Publisher

Elsevier BV

Subject

Oncology,General Medicine,Surgery

Reference24 articles.

1. Esophageal cancer;Enzinger;N Engl J Med,2003

2. Patterns of operative mortality following esophagectomy;Schieman;Dis Esophagus,2012

3. Predictors of postoperative morbidity and mortality after surgery for gastro-oesophageal carcinomas;Liedman;Eur J Surg,1995

4. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis;Sjoquist;Lancet Oncol,2011

5. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in locally advanced esophageal cancer: An updated meta-analysis;Medicine;2024-01-19

2. Clinical study of camrelizumab combined with docetaxel and carboplatin as a neoadjuvant treatment for locally advanced oesophageal squamous cell carcinoma;Diseases of the Esophagus;2024-01-06

3. Short-course neoadjuvant radiotherapy combined with chemotherapy and toripalimab for locally advanced esophageal squamous cell carcinoma (SCALE-1): a single-arm phase Ib clinical trial;Journal for ImmunoTherapy of Cancer;2024-01

4. Correlation between 8-OHdG and disease-free survival in patients with esophageal squamous cell carcinoma following neoadjuvant chemotherapy;2023-10-24

5. Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol;Trials;2023-08-25